Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
284 | EPC - European Pharmaceutical Contractor | journal | 3 | 7 | 0 | 20 | 0 | 0 | 0.00 | 2.86 | 28.57 | ||
283 | Handbook of Experimental Pharmacology | journal | 0.303 Q2 | 110 | 81 | 357 | 8456 | 900 | 2 | 2.56 | 104.40 | 0.00 | |
282 | Pharmaceutical Technology in Hospital Pharmacy | journal | 0.211 Q4 | 1 | 0 | 2 | 0 | 4 | 2 | 0.00 | 0.00 | 0.00 | |
281 | Ergebnisse der Physiologie Biologischen Chemie und Experimentellen Pharmakologie | journal | 0.416 Q3 | 12 | 19 | 44 | 2934 | 116 | 9 | 2.56 | 154.42 | 0.00 | |
280 | Circular Farmaceutica | journal | 0.103 Q4 | 3 | 0 | 11 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | |
279 | European Journal of Oncology Pharmacy | journal | 0.200 Q4 | 6 | 8 | 17 | 169 | 21 | 17 | 1.00 | 21.13 | 56.67 | |
278 | Drug Discovery Today: Disease Models | journal | 0.665 Q2 | 33 | 0 | 23 | 0 | 64 | 20 | 0.00 | 0.00 | 0.00 | |
277 | Drug Target Insights | journal | 0.429 Q2 | 16 | 16 | 23 | 617 | 52 | 22 | 2.28 | 38.56 | 29.82 | |
276 | Antiviral Chemistry and Chemotherapy | journal | 0.369 Q3 | 59 | 2 | 29 | 41 | 62 | 28 | 0.87 | 20.50 | 0.00 | |
275 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.166 Q3 | 7 | 13 | 35 | 214 | 10 | 34 | 0.24 | 16.46 | 30.77 | |
274 | Medical Cannabis and Cannabinoids | journal | 0.731 Q2 | 13 | 19 | 41 | 621 | 168 | 34 | 3.65 | 32.68 | 39.53 | |
273 | Journal of International Peacekeeping | journal | 0.216 Q3 | 14 | 24 | 40 | 1699 | 29 | 38 | 0.87 | 70.79 | 60.00 | |
272 | Journal of Xenobiotics | journal | 1.246 Q1 | 11 | 48 | 41 | 3816 | 302 | 40 | 7.37 | 79.50 | 46.05 | |
271 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.726 Q2 | 13 | 18 | 47 | 751 | 163 | 41 | 3.74 | 41.72 | 36.17 | |
270 | European Pharmaceutical Law Review | journal | 0.162 Q3 | 4 | 0 | 71 | 0 | 19 | 42 | 0.20 | 0.00 | 0.00 | |
269 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.446 Q1 | 99 | 16 | 44 | 2659 | 318 | 44 | 7.14 | 166.19 | 46.38 | |
268 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.138 Q4 | 5 | 17 | 46 | 385 | 3 | 45 | 0.00 | 22.65 | 71.43 | |
267 | Pharmakeftiki | journal | 0.125 Q4 | 6 | 14 | 47 | 500 | 6 | 45 | 0.11 | 35.71 | 40.38 | |
266 | Drug Discovery Today: Technologies | journal | 1.241 Q1 | 62 | 0 | 53 | 0 | 295 | 48 | 3.50 | 0.00 | 0.00 | |
265 | Pharmaceutical patent analyst | journal | 0.351 Q2 | 20 | 26 | 62 | 1235 | 71 | 50 | 1.18 | 47.50 | 39.62 | |
264 | European Pharmaceutical Journal | journal | 0.148 Q4 | 9 | 18 | 59 | 401 | 27 | 59 | 0.33 | 22.28 | 56.10 | |
263 | Biomedical and Biopharmaceutical Research | journal | 0.133 Q4 | 4 | 18 | 66 | 651 | 21 | 62 | 0.15 | 36.17 | 58.21 | |
262 | Mathematical Medicine and Biology | journal | 0.276 Q3 | 49 | 15 | 63 | 536 | 67 | 63 | 1.10 | 35.73 | 33.33 | |
261 | Medicine in Drug Discovery | journal | 0.815 Q2 | 16 | 20 | 68 | 1878 | 328 | 65 | 4.83 | 93.90 | 45.00 | |
260 | Geneesmiddelenbulletin | journal | 0.158 Q4 | 7 | 17 | 68 | 307 | 5 | 68 | 0.07 | 18.06 | 23.08 | |
259 | Drug Delivery Letters | journal | 0.185 Q3 | 7 | 25 | 82 | 1365 | 67 | 79 | 0.63 | 54.60 | 42.03 | |
258 | Expert Review of Precision Medicine and Drug Development | journal | 0.257 Q3 | 16 | 3 | 102 | 251 | 92 | 79 | 0.90 | 83.67 | 42.86 | |
257 | International Journal of Computational Biology and Drug Design | journal | 0.120 Q4 | 16 | 14 | 80 | 527 | 27 | 79 | 0.50 | 37.64 | 35.56 | |
256 | Expert Opinion on Orphan Drugs | journal | 0.199 Q3 | 27 | 3 | 85 | 174 | 66 | 82 | 0.86 | 58.00 | 30.00 | |
255 | Biopharmaceutics and Drug Disposition | journal | 0.396 Q2 | 65 | 36 | 91 | 1728 | 188 | 89 | 1.91 | 48.00 | 39.67 | |
254 | Current Research in Toxicology | journal | 0.722 Q2 | 12 | 40 | 93 | 2665 | 292 | 91 | 3.24 | 66.63 | 40.00 | |
253 | International Journal of Pharmaceutics: X | journal | 0.801 Q1 | 23 | 74 | 91 | 4239 | 495 | 91 | 5.47 | 57.28 | 49.63 | |
252 | ATLA Alternatives to Laboratory Animals | journal | 0.397 Q3 | 65 | 34 | 119 | 1450 | 187 | 92 | 1.35 | 42.65 | 41.72 | |
251 | Chemotherapy | journal | 0.663 Q2 | 61 | 30 | 97 | 866 | 219 | 92 | 1.84 | 28.87 | 35.75 | |
250 | Current Pharmacology Reports | journal | 0.624 Q2 | 35 | 40 | 95 | 4209 | 411 | 92 | 3.69 | 105.23 | 45.93 | |
249 | Food Additives and Contaminants | journal | 0.364 Q3 | 121 | 124 | 92 | 5425 | 186 | 92 | 1.81 | 43.75 | 47.41 | |
248 | Food Hydrocolloids for Health | journal | 0.932 Q1 | 13 | 64 | 93 | 4066 | 471 | 92 | 5.06 | 63.53 | 41.88 | |
247 | PZ Prisma | journal | 0.100 Q4 | 5 | 21 | 103 | 311 | 0 | 92 | 0.00 | 14.81 | 34.48 | |
246 | Pharmaceutical Medicine | journal | 0.732 Q2 | 25 | 47 | 107 | 2050 | 275 | 93 | 2.59 | 43.62 | 41.73 | |
245 | EJNMMI Radiopharmacy and Chemistry | journal | 0.869 Q2 | 28 | 42 | 99 | 1553 | 398 | 95 | 3.59 | 36.98 | 37.30 | |
244 | Pharmaceutical Nanotechnology | journal | 0.371 Q2 | 22 | 42 | 108 | 2713 | 236 | 96 | 1.96 | 64.60 | 42.65 | |
243 | Toxicon: X | journal | 0.870 Q1 | 16 | 20 | 97 | 1404 | 356 | 96 | 4.11 | 70.20 | 35.77 | |
242 | Mycotoxin Research | journal | 0.428 Q3 | 46 | 33 | 99 | 1953 | 279 | 97 | 2.39 | 59.18 | 45.36 | |
241 | Antiviral Therapy | journal | 0.447 Q3 | 93 | 24 | 105 | 935 | 154 | 102 | 1.45 | 38.96 | 47.24 | |
240 | Expert Opinion on Emerging Drugs | journal | 0.881 Q2 | 54 | 29 | 110 | 2695 | 321 | 102 | 2.62 | 92.93 | 36.28 | |
239 | Journal of Liposome Research | journal | 0.747 Q1 | 64 | 46 | 102 | 3388 | 565 | 102 | 4.11 | 73.65 | 54.42 | |
238 | Skin Pharmacology and Physiology | journal | 0.623 Q2 | 86 | 20 | 106 | 1053 | 277 | 105 | 2.89 | 52.65 | 47.06 | |
237 | PharmaNutrition | journal | 0.451 Q3 | 30 | 32 | 116 | 2047 | 309 | 106 | 2.78 | 63.97 | 50.63 | |
236 | Drugs in R and D | journal | 0.708 Q2 | 54 | 40 | 111 | 1687 | 296 | 107 | 2.41 | 42.18 | 50.97 | |
235 | Food Additives and Contaminants: Part B Surveillance | journal | 0.557 Q3 | 41 | 39 | 107 | 1681 | 336 | 107 | 3.07 | 43.10 | 51.12 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®